Seroprevalence and Risk Factors of Toxocara canis Infection in Children (2–15 Years Old) Referred to Health Centers of Lorestan Province, Iran

Abstract

This study aims to evaluate the seroprevalence and risk factors for Toxocara canis infection in children (2–15 years old) referred to health centers of Lorestan province, Iran. This cross-sectional study was performed from August 2016 to March 2017 on 316 children. All serum samples were tested using the commercially available anti IgG-Toxocara kit (IBL, Germany) according to manufacturer's instructions. Of the 316 children, 14 (4.4%) tested seropositive for anti-T.canis IgG antibody. The variables used to evaluate association between risk factors and status of anti-T. canis IgG antibodies were age, gender, area of residence, eosinophilia, contact with dogs, and consumption of raw or unwashed vegetables and fruits. Risk factors that were significantly related to T. canis seropositivity included living in rural regions (p = 0.018) and contact with dogs (p = 0.001). However, other demographic and risk factors did not demonstrate any association with T. canis seropositivity. To conclude, we found that T. canis infection is prevalent among children (2–15 years old) referred to health centers of Lorestan province, Iran with an overall seroprevalence rate of 4.4%. These findings may be a warning for health centers to pay special attention to toxocariasis among children (2–15 years old) and design screening programs for its prevention.

Keywords

toxocariasis - ELISA - IgG - Lorestan

• References

• 1 Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 2003; 16 (02) 265-272
• 2 Macpherson CN. The epidemiology and public health importance of toxocariasis: a zoonosis of global importance. Int J Parasitol 2013; 43 (12–13): 999-1008
• 3 Fan CK, Liao CW, Cheng YC. Factors affecting disease manifestation of toxocarosis in humans: genetics and environment. Vet Parasitol 2013; 193 (04) 342-352
• 4 Moreira GM, Telmo PdeL, Mendonça M, Moreira AN, McBride AJ, Scaini CJ, Conceição FR. Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol 2014; 30 (09) 456-464
• 5 Weatherhead JE, Hotez PJ. Worm infections in children. Pediatr Rev 2015; 36 (08) 341-352 ; quiz 353–354
• 6 Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol 2010; 104 (01) 3-23
• 7 Mahmoudvand H, Saedi Dezaki E, Soleimani S, Baneshi MR, Kheirandish F, Ezatpour B, Zia-Ali N. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran. Parasite Immunol 2015; 37 (07) 362-367
• 8 Abdi J, Darabi M, Sayehmiri K. Epidemiological situation of toxocariasis in Iran: meta-analysis and systematic review. Pak J Biol Sci 2012; 15 (22) 1052-1055
• 9 Abo-Shehada MN, Sharif L, el-Sukhon SN, Abuharfeil N, Atmeh RF. Seroprevalence of Toxocara canis antibodies in humans in northern Jordan. J Helminthol 1992; 66 (01) 75-78
• 10 Mughini-Gras L, Harms M, van Pelt W, Pinelli E, Kortbeek T. Seroepidemiology of human Toxocara and Ascaris infections in the Netherlands. Parasitol Res 2016; 115 (10) 3779-3794
• 11 Gungor C, Ciftci E, Aral Akarsu G. Prevalance of Toxocara antibodies in children with idiopathic abdominal pain. Turkiye Parazitol Derg 1999; 23: 24-27
• 12 Gabrielli S, Tasić-Otašević S, Ignjatović A. , et al. Seroprevalence and risk factors for Toxocara canisinfection in Serbia during 2015. Foodborne Pathog Dis 2017; 14 (01) 43-49
• 13 Cassenote AJ, Lima AR, Pinto Neto JM, Rubinsky-Elefant G. Seroprevalence and modifiable risk factors for Toxocara spp. in Brazilian schoolchildren. PLoS Negl Trop Dis 2014; 8 (05) e2830
• 14 Sadjjadi SM, Khosravi M, Mehrabani D, Orya A. Seroprevalence of Toxocara infection in school children in Shiraz, southern Iran. J Trop Pediat r 2000; 46 (06) 327-330
• 15 Akhlaghi L, Ourmazdi H, Sarafnia A, Vaziri S, Jadidian K, Leghaii Z. An investigation on the toxocariasis seroprevalence in children (2–12 years old) from Mahidashtarea of Kermanshah province (2003–2004). Razi J Med Sci 2006; 13 (52) 41-48
• 16 Ghaffar-Naqnehi A H, Khalili B, Kheiri S. Seroepidemiology of Toxocara canis infection in 2–14 years old children referred to health care centers of Chaharmahal and Bakhtiari province. J Shahrekord Univ Med Sci 2016; 17 (06) 121-129
• 17 Alavi SM, Hosseini SA, Rahdar M, Salmanzadeh SH, Nikkhuy AR. Determination of seroprevalence rate of Toxocaracanis in 6–15 years aged rural and urban school children in Ahvaz, Iran. J Jundishapur Univ Med Sci 2011; 3 (72) 240-248
• 18 Fallah M, Azimi A, Taherkhani H. Seroprevalence of toxocariasis in children aged 1-9 years in western Islamic Republic of Iran, 2003. East Mediterr Health J 2007; 13 (05) 1073-1077
• 19 Alonso JM, Bojanich MV, Chamorro M, Gorodner JO. Toxocara seroprevalence in children from a subtropical city in Argentina. Rev Inst Med Trop Sao Paulo 2000; 42 (04) 235-237
• 20 Anaruma Filho F, Chieffi PP, Correa CR. , et al. Human toxocariasis: a seroepidemiological survey in the municipality of Campinas (SP), Brazil. Rev Inst Med Trop Sao Paulo 2002; 44 (06) 303-307
• 21 Hosseini-Safa A, Mousavi SM, Bahadoran Bagh Badorani M. , et al. Seroepidemiology of toxocariasis in children (5–15 yr old) referred to the pediatric clinic of Imam Hossein Hospital, Isfahan, Iran. Iran J Parasitol 2015; 10 (04) 632-637
• 22 Overgaauw PA. Aspects of Toxocara epidemiology: human toxocarosis. Crit Rev Microbiol 1997; 23 (03) 215-231